Search

everythinglearnresearchcommunity

for

Search:↓

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

The new Hairless R/J mice model improves imaging for tumor monitoring and cancer therapy evaluation.

The combination treatment showed some improvement but wasn't significantly better than using betamethasone valerate alone.

Baricitinib successfully regrew hair in an 8-year-old boy with alopecia totalis linked to a KRT74 gene variant.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

A group has developed therapies that show promise for treating cancer and various other conditions.

The nano-carrier makes etoposide safer and more effective against lung cancer.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

Tigers had a skin condition causing hair loss and inflammation, but the cause is unknown and treatment didn't work.

Tralokinumab effectively improved atopic dermatitis symptoms in most patients, but some stopped due to side effects like hair loss.

The model helps test drugs for clubfoot fibrosis by mimicking cell environments and shows minoxidil reduces harmful collagen links.

Researchers developed a reliable method to measure testosterone and epitestosterone in urine for medical and anti-doping use.

Avian yolk antibodies offer a promising, ethical alternative for disease prevention and therapy.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Newly designed proteins can effectively degrade specific proteins in cells, offering a potential new therapy method.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Mycophenolate mofetil can effectively treat autoimmune hepatitis when standard drugs fail.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

Oral Janus kinase inhibitors are effective for treating alopecia areata in adults.

Proton minibeam radiotherapy shows promise for sparing healthy tissue in cancer treatment but needs further research and technological development.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Early treatment with JAK inhibitors leads to better hair regrowth in acute alopecia areata.

Patients with alopecia areata using Janus kinase inhibitors are not following lab monitoring guidelines.

Aumolertinib is effective and well-tolerated for treating advanced lung cancer with EGFR mutations.

Intravenous arsenic is safe and effective for treating certain blood cancers.